Buthionine sulfoximine enhanced melphalan cytotoxic activity against multiple myeloma cell lines

被引：0
|
作者：
Tagde, Ashujit [1 ]
Reynolds, C. Patrick [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Canc, Lubbock, TX 79430 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-2239
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2239
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
    Tagde, A.
    Singh, H.
    Kang, M. H.
    Reynolds, C. P.
    BLOOD CANCER JOURNAL, 2014, 4 : e229 - e229
  • [2] The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
    A Tagde
    H Singh
    M H Kang
    C P Reynolds
    Blood Cancer Journal, 2014, 4 : e229 - e229
  • [3] Synergism of buthionine sulfoximine and melphalan against neuroblastoma cell lines derived after disease progression
    Anderson, CP
    Keshelava, N
    Satake, N
    Meek, WH
    Reynolds, CP
    MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 35 (06): : 659 - 662
  • [4] Enhancement of melphalan activity by buthionine sulfoximine and electroporation in melanoma cells
    Ongaro, Alessia
    Pellati, Agnese
    De Mattei, Monica
    De Terlizzi, Francesca
    Rossi, Carlo R.
    Campana, Luca G.
    ANTI-CANCER DRUGS, 2015, 26 (03) : 284 - 292
  • [5] Depletion of glutathione by buthionine sulfoximine is cytotoxic for human neuroblastoma cell lines via apoptosis
    Anderson, CP
    Tsai, JM
    Meek, WE
    Liu, RM
    Tang, YM
    Forman, HJ
    Reynolds, CP
    EXPERIMENTAL CELL RESEARCH, 1999, 246 (01) : 183 - 192
  • [6] POTENTIATION OF MELPHALAN CYTO-TOXICITY BY BUTHIONINE-SULFOXIMINE IN 4 MELANOMA CELL-LINES
    ALVEROJACKSON, H
    BENATHAN, M
    FRENK, E
    CLINICAL RESEARCH, 1989, 37 (02): : A714 - A714
  • [7] POTENTIATION OF MELPHALAN CYTO-TOXICITY BY BUTHIONINE-SULFOXIMINE IN 4 MELANOMA CELL-LINES
    ALVEROJACKSON, H
    BENATHAN, M
    FRENK, E
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) : 395 - 395
  • [8] Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line
    Anderson, CP
    Seeger, RC
    Satake, N
    Monforte-Munoz, HL
    Keshelava, N
    Bailey, HH
    Reynolds, CP
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (08) : 500 - 505
  • [9] Modulation of melphalan cytotoxic activity in human melanoma cell lines
    Supino, R
    Caserini, C
    Orlandi, L
    Zaffaroni, N
    Silvestrini, R
    Vaglini, M
    Zunino, F
    ANTI-CANCER DRUGS, 1996, 7 (05) : 604 - 612
  • [10] Glutathione homeostasis in buthionine sulfoximine sensitive and resistant neuroblastoma cell lines
    Case, MC
    Hall, AG
    BRITISH JOURNAL OF CANCER, 2000, 83 : 64 - 64
12345